期刊文献+

高效液相色谱-串联质谱法测定人血浆中多尼培南的浓度 被引量:5

Determination of doripenem concentration in human plasma by liquid chromatography tandem mass spectrometry
原文传递
导出
摘要 目的建立高效液相色谱-质谱联用(LC-MS-MS)法测定人血浆内多尼培南浓度的方法。方法采用Agilent Zorbax C18(2.1mm×150mm,5μm)色谱柱;柱温25℃;流动相为甲醇-水(含10mmol·L-1乙酸铵)(32∶68,V/V);流速为0.2mL·min-1;通过LC-MS-MS,电喷雾离子源(ESI),以多反应监测(MRM)方式进行检测;离子极性监测负离子(-);检测离子为多尼培南m/z419.8[M-H]-→331.4[M-H-C4H7O2]-,法罗培南(内标)m/z284.2[M-H]-→196.1[M-H-C4H7O2]-。结果多尼培南的最低定量限为3.003μg·L-1,线性范围为3.003~10010μg·L-1(r=0.9982)。结论该方法简便、灵敏度高,可以用来进行多尼培南的人体药动学和生物等效性研究。 AIM To establish high-performance liquid chromatographic tandem mass spectrometric method for the determination of doripenem concentration in human plasma. METHODS Agilent Zorbax C18 (2.1 mm × 150 mm, 5 μm) chromatographic column with 25℃ column temperature. The mobile phase consisted of methanol/10 mmol·L^-1 ammonium acetate (32 : 68, V/V) and flow rate was 0.2 mL·min^-1. A Waters Micromass Quattro micro tandem mass spectrometer equipped with electronic spray ionization source were used as detector and operated in the negative ion mode under multi reaction monitoring (MRM). The ion of doripenem to detect was m/z 419.8 [M-H]^-→331.4 [M-H-C4H7O2]^- , and the faropenem ion (internal standard) was m/z 284.2 [M-H]-→196.1 [M-H-C4H7O2]^-. RESULTS The lowest qualification limit of doripenem was 3.003 μg·L^-1. The linear concentration range was 3.003 - 10 010 μg·L^-1 with standard correlation coefficient of (r = 0.998 2).CONCLUSION This method is simple, sensitive, and suitable for clinical pharmacokinetics and bioequivalence studies for doripenem.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2009年第5期380-384,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 多尼培南 血浆 色谱法 高压液相 光谱法 质量 电喷雾电离 doripenem plasma chromatography, high pressure liquid spectrometry, mass, electrospray ionization
  • 相关文献

参考文献4

  • 1NOMURA S, NAGAYAMA A. In vitro antibacterial activity of S- 4661, a new parenteral carbapenem, against urological pathogens isolated from patients with complicated urinary tract infections [J]. J Chemother, 2002, 14(2) : 155-160.
  • 2封宇飞.2007年美国FDA批准的新药[J].中国新药与临床杂志,2008,27(3):231-233. 被引量:3
  • 3SUTHERLAND C, NICOLAU DP. Development of an HPLC method for the determination of doripenem in human and mouse serum [J]. J Chromatogr B, 2007, 853(1-2) : 123-126.
  • 4IKEDA K, IKAWA K, MORIKAWA N, et al. Quantification of doripenem in human plasma and peritoneal fluid by highperformance liquid chromatography with ultraviolet detection [J]. J Chromatogr B, 2008, 867 ( 1 ) : 20-25.

二级参考文献1

共引文献2

同被引文献571

  • 1陈庄元,董立莎,曹佩雪,梁光义.不同栀子金花汤煎液中3种成分的变化及抑菌作用的比较[J].华西药学杂志,2008,23(2):135-137. 被引量:6
  • 2朱兰,冯芳,任杨帆,叶小敏,张璐璐.多种色谱-波谱联用技术分析栀子厚朴汤中特征成分及其配伍前后的溶出变化[J].中国药科大学学报,2009,40(5):426-430. 被引量:9
  • 3史军.药物动力学和药效动力学在抗菌药物新药开发和临床治疗上的应用[J].中国临床药理学与治疗学,2007,12(2):121-133. 被引量:34
  • 4KANIGA K, FLAMM R, TONG SY, et al. Worldwide experience with the use of doripenem against extended- spectrum- - lactamase- producing and ciprofloxacin- resistant Enterobacteria- ceae: analysis of six phase 3 clinical studies [J]. Antimicrob Agents Chemother, 2010, 54(5): 2119-2124.
  • 5FUJ1MURA T, KIMURA Y, YOSHIDA I, et al. In vitro antibacterial activity of doripenem, a novel parenteral carba- penem[J]. Jpn J Chemother, 2005, 53(S-1): 57-70.
  • 6MUSHTAQ S, GE Y, LIVERMORE DM. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized 13- lactamases[J]. Antimicrob Agents Chemother, 2004, 48 (4): 1313-1319.
  • 7MARTI S, SANCHEZ-CESPEDES J, ALBA V, et ol. In vitro activity of doripenem against Acinetobacter baumannii clinicalisolates[J]. Int J Antimicrob Agents, 2009, 33(2): 181-182.
  • 8ZHANEL GG, WIEBE R, DILAY L, et al. Comparative review of the carbapenems[J]. Drugs, 2007, 67(7) : 1027-1052.
  • 9HAMMAMI S, GHOZZI R, SAIDANI M, et d. Carbapenem- resistant Acinetobacter baunumnii producing the carbapenemase OXA-23 in Tunisia[J]. Tunis Med, 2011, 89(7): 638-643.
  • 10RUMBO C, FERNANDEZ-MOREIRA E, MERINO M, et al. Horizontal transfer of the OXA-24 carbapenemase gene via outer membrane vesicles: a new mechanism of dissemination of carbapenem resistance genes in Acinetobacter baumannii [J]. Antimicrob Agents Chemother, 2011, 55 (7) : 3084-3090.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部